Our consortium brings together basic and clinical expertise of internationally recognized groups with complementary core competencies from clinical trials to neurobiology. Partners have a long track record of collaboration and share robust common resources and cross-validated protocols ensuring the reproducibility of the results.
The consortium is composed of a total of five organizations from four countries.
This is an EU Joint Program - Neurodegenerative Disease Research (JPND) project. JPND is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.
The project is supported through the following funding organizations under the aegis of JPND: Spain: Instituto de Salud Carlos III (ISCIII), France: Agence Nationale de la Recherche (ANR), United Kingdom: Medical Research Council (MRC), Netherlands: The Netherlands Organization for Health Research and Development (ZonMw).